{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T19:47:43Z","timestamp":1794080863834,"version":"4.8.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Drug Delivery Science and Technology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.jddst.2022.103587","type":"journal-article","created":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T12:21:27Z","timestamp":1657542087000},"page":"103587","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Lopinavir-menthol co-crystals for enhanced dissolution rate and intestinal absorption"],"prefix":"10.1016","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5693-728X","authenticated-orcid":false,"given":"Noha D.","family":"Fayed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona F.","family":"Arafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebtesam A.","family":"Essa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5531-710X","authenticated-orcid":false,"given":"Gamal M.","family":"El Maghraby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jddst.2022.103587_bib1","article-title":"The latest evidence for possible HIV-1 curative strategies","volume":"7","author":"Pham","year":"2018","journal-title":"Drugs Context (US)"},{"key":"10.1016\/j.jddst.2022.103587_bib2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3390\/pharmaceutics11020097","article-title":"Freeze-dried lopinavir-loaded nanostructured lipid carriers for enhanced cellular uptake and bioavailability: statistical optimization, in vitro and in vivo evaluations","volume":"11","author":"Khan","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jddst.2022.103587_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.631480","article-title":"Dosage, and adherence of antiretroviral therapy and risk of osteoporosis in patients with human immunodeficiency virus infection in taiwan: a nested case-control study","volume":"12","author":"Chiu","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jddst.2022.103587_bib4","doi-asserted-by":"crossref","first-page":"904","DOI":"10.3390\/pharmaceutics13060904","article-title":"Development of in situ self-assembly nanoparticles to encapsulate lopinavir and ritonavir for long-acting subcutaneous injection","volume":"13","author":"Tanaudommongkon","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jddst.2022.103587_bib5","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3390\/ijms22020683","article-title":"Protease inhibitor anti-HIV, lopinavir, impairs placental endocrine function","volume":"22","author":"Fraichard","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jddst.2022.103587_bib6","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1021\/acs.chemrestox.1c00028","article-title":"Inhibition of CYP3A7 DHEA-S oxidation by lopinavir and ritonavir: an alternative mechanism for adrenal impairment in HIV antiretroviral-treated neonates","volume":"34","author":"Kandel","year":"2021","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.jddst.2022.103587_bib7","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/INF.0000000000003055","article-title":"Pharmacokinetics and safety of zidovudine, lamivudine, and lopinavir\/ritonavir in HIV-infected children with severe acute malnutrition in sub-saharan africa: IMPAACT protocol P1092","volume":"40","author":"Owor","year":"2021","journal-title":"J. Pediatr. Infect. Dis."},{"key":"10.1016\/j.jddst.2022.103587_bib8","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1080\/14756366.2020.1724994","article-title":"Aspartic peptidase of Phialophora verrucosa as target of HIV peptidase inhibitors: blockage of its enzymatic activity and interference with fungal growth and macrophage interaction","volume":"35","author":"Granato","year":"2020","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.jddst.2022.103587_bib9","doi-asserted-by":"crossref","first-page":"424","DOI":"10.3390\/jof7060424","article-title":"Repositioning lopinavir, an HIV protease inhibitor, as a promising antifungal drug: lessons learned from Candida albicans\u2014in silico, in vitro and in vivo approaches","volume":"7","author":"Santos","year":"2021","journal-title":"J. Fungi"},{"key":"10.1016\/j.jddst.2022.103587_bib10","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1017\/S0031182018000823","article-title":"Lopinavir, an HIV-1 peptidase inhibitor, induces alteration on the lipid metabolism of Leishmania amazonensis promastigotes","volume":"145","author":"Rebello","year":"2018","journal-title":"Parasitology"},{"key":"10.1016\/j.jddst.2022.103587_bib11","first-page":"120","article-title":"Lopinavir and nelfinavir induce the accumulation of crystalloid lipid inclusions within the reservosomes of trypanosoma cruzi and inhibit both aspartyl-type peptidase and cruzipain activities detected in these crucial organelles","volume":"6","author":"Sangenito","year":"2021","journal-title":"Trav. Med. Infect. Dis."},{"key":"10.1016\/j.jddst.2022.103587_bib12","first-page":"114","article-title":"Tailoring supersaturation from amorphous solid dispersions","volume":"10","author":"Li","year":"2018","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.jddst.2022.103587_bib13","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/FTD.0000000000000838","article-title":"Plasma concentrations and safety of lopinavir\/ritonavir in COVID-19 patients","volume":"43","author":"Chouchana","year":"2021","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jddst.2022.103587_bib14","first-page":"2435","article-title":"Early combination treatment with existing HIV antivirals: an effective treatment for COVID-19","volume":"25","author":"Dallocchio","year":"2021","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.jddst.2022.103587_bib15","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1080\/07853890.2021.1875500","article-title":"Efficacy of the current investigational drugs for the treatment of COVID-19: a scoping review","volume":"53","author":"Wadaa-Allah","year":"2021","journal-title":"Ann. Med."},{"key":"10.1016\/j.jddst.2022.103587_bib16","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jpba.2008.02.014","article-title":"Development and validation of dissolution test for lopinavir, a poorly water-soluble drug, in soft gel capsules, based on in vivo data","volume":"47","author":"Donato","year":"2008","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jddst.2022.103587_bib17","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.2217\/nnm.12.181","article-title":"Surface-stabilized lopinavir nanoparticles enhance oral bioavailability without coadministration of ritonavir","volume":"8","author":"Jain","year":"2013","journal-title":"Nanomedicine. (Lond)."},{"key":"10.1016\/j.jddst.2022.103587_bib18","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3390\/ph7040433","article-title":"Amino acid prodrugs: an approach to improve the absorption of HIV-1 protease inhibitor, lopinavir","volume":"7","author":"Patel","year":"2014","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jddst.2022.103587_bib19","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.colsurfb.2016.02.012","article-title":"Systematic development of solid self-nanoemulsifying oily formulations (S-SNEOFs) for enhancing the oral bioavailability and intestinal lymphatic uptake of lopinavir","volume":"141","author":"Garg","year":"2016","journal-title":"Colloids Surf., B"},{"key":"10.1016\/j.jddst.2022.103587_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120657","article-title":"Development of stable amorphous solid dispersion and quantification of crystalline fraction of lopinavir by spectroscopic-chemometric methods","volume":"602","author":"Hamed","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jddst.2022.103587_bib21","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jconrel.2016.02.001","article-title":"Development and in vivo evaluation of child-friendly lopinavir\/ritonavir pediatric granules utilizing novel in situ self-assembly nanoparticles","volume":"226","author":"Pham","year":"2016","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.jddst.2022.103587_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2020.e03890","article-title":"Nanoformulated Eudragit lopinavir and preliminary release of its loaded suppositories","volume":"6","author":"Katata-Seru","year":"2020","journal-title":"Heliyon"},{"key":"10.1016\/j.jddst.2022.103587_bib23","article-title":"Amorphous solid dispersion formation via solvent granulation \u2013 a case study with ritonavir and lopinavir","volume":"1","author":"Trasi","year":"2019","journal-title":"Int. J. Pharm. X."},{"key":"10.1016\/j.jddst.2022.103587_bib24","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/j.xphs.2017.05.004","article-title":"Developing a flexible pediatric dosage form for antiretroviral therapy: a fast-dissolving tablet","volume":"106","author":"Lal","year":"2017","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.jddst.2022.103587_bib25","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.3109\/03639045.2015.1118495","article-title":"Sucralose as co-crystal co-former for hydrochlorothiazide: development of oral disintegrating tablets","volume":"42","author":"Arafa","year":"2016","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jddst.2022.103587_bib26","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1080\/10837450.2016.1242625","article-title":"Xylitol as a potential co-crystal co-former for enhancing dissolution rate of felodipine: preparation and evaluation of sublingual tablets","volume":"23","author":"Arafa","year":"2018","journal-title":"Pharmaceut. Dev. Technol."},{"key":"10.1016\/j.jddst.2022.103587_bib27","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ijpharm.2019.04.024","article-title":"Eutexia for enhanced dissolution rate and anti-inflammatory activity of nonsteroidal anti-inflammatory agents: caffeine as a melting point modulator","volume":"563","author":"Alshaikh","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jddst.2022.103587_bib28","article-title":"Coamorphisation of acetyl salicylic acid and curcumin for enhancing dissolution, anti-inflammatory effect and minimizing gastro toxicity","volume":"61","author":"Mohapatra","year":"2021","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.jddst.2022.103587_bib29","first-page":"1","article-title":"Pharmaceutical applications of eutectic mixtures","volume":"2","author":"Gala","year":"2013","journal-title":"J. Develop. Drugs."},{"key":"10.1016\/j.jddst.2022.103587_bib30","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3390\/pharmaceutics11030112","article-title":"Drug solubility enhancement through the preparation of multicomponent organic materials: eutectics of lovastatin with carboxylic acids","volume":"11","author":"Araya-Sibaja","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jddst.2022.103587_bib31","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.3390\/molecules25051077","article-title":"Design of deep eutectic systems: a simple approach for preselecting eutectic mixture constituents","volume":"25","author":"Alhadid","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.jddst.2022.103587_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119741","article-title":"Eutectic mixtures as an approach to enhance solubility, dissolution rate and oral bioavailability of poorly water-soluble drugs","volume":"588","author":"Bazzo","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jddst.2022.103587_bib33","doi-asserted-by":"crossref","first-page":"5078","DOI":"10.1039\/c2ce06602e","article-title":"Pharmaceutical cocrystals of nitrofurantoin: screening, characterization, and crystal structure analysis","volume":"14","author":"Alhalaweh","year":"2012","journal-title":"CrystEngComm"},{"key":"10.1016\/j.jddst.2022.103587_bib34","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1134\/S107036321402042X","article-title":"Design of pharmaceutical cocrystals for drug solubility improvement","volume":"84","author":"Perlovich","year":"2014","journal-title":"Russ. J. Gen. Chem."},{"key":"10.1016\/j.jddst.2022.103587_bib35","first-page":"14833","volume":"20","author":"Stoler","year":"2015","journal-title":"Non-Covalent Derivatives: Cocrystals and Eutectics Molecules"},{"key":"10.1016\/j.jddst.2022.103587_bib36","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1208\/s12249-016-0701-1","article-title":"Drug-drug multicomponent solid forms: cocrystal, coamorphous and eutectic of three poorly soluble antihypertensive drugs using mechanochemical approach","volume":"18","author":"Haneef","year":"2017","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jddst.2022.103587_bib37","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0378-5173(00)00505-6","article-title":"Physicochemical studies of lidocaine-menthol binary systems for enhanced membrane transport","volume":"206","author":"Kang","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jddst.2022.103587_bib38","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijpharm.2003.09.013","article-title":"Enhanced rectal bioavailability of ibuprofen in rats by poloxamer 188 and menthol","volume":"269","author":"Yong","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jddst.2022.103587_bib39","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jconrel.2004.09.016","article-title":"Effect of L-menthol and 1,8-cineole on phase behavior and molecular organization of SC lipids and skin permeation of zidovudine","volume":"102","author":"Narishetty","year":"2005","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.jddst.2022.103587_bib40","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ijpharm.2006.08.011","article-title":"Delivery of 125I-cobrotoxin after intranasal administration to the brain: a microdialysis study in freely moving rats","volume":"328","author":"Li","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jddst.2022.103587_bib41","first-page":"699","article-title":"C. CavaleiroP-glycoprotein mediated efflux modulators of plant origin: a short review","volume":"11","author":"Silva","year":"2016","journal-title":"Nat. Prod. Commun."},{"key":"10.1016\/j.jddst.2022.103587_bib42","doi-asserted-by":"crossref","first-page":"5420","DOI":"10.1021\/jp101303j","article-title":"Lidocaine\/L-menthol binary system: cocrystallization versus solid-state immiscibility","volume":"114","author":"Corvis","year":"2010","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.jddst.2022.103587_bib43","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.2147\/IJN.S108355","article-title":"Transformation of eutectic emulsion to nanosuspension fabricating with solvent evaporation and ultrasonication technique","volume":"11","author":"Phaechamud","year":"2016","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.jddst.2022.103587_bib44","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1080\/10837450.2019.1682609","article-title":"Preparation of stabilized submicron fenofibrate crystals on niacin as a hydrophilic hydrotropic carrier","volume":"25","author":"Alshaikh","year":"2020","journal-title":"Pharmaceut. Dev. Technol."},{"key":"10.1016\/j.jddst.2022.103587_bib45","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.2042-7158.1975.tb09378.x","article-title":"The concept of dissolution efficiency","volume":"27","author":"Khan","year":"1975","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jddst.2022.103587_bib46","doi-asserted-by":"crossref","first-page":"142","DOI":"10.4103\/0250-474X.54281","article-title":"Mathematical approach for the assessment of similarity factor using a new scheme for calculating weight","volume":"71","author":"Gohel","year":"2009","journal-title":"Indian J. Pharmaceut. Sci."},{"key":"10.1016\/j.jddst.2022.103587_bib47","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1023\/A:1015817426713","article-title":"Absorptive clearance of carbamazepine and selected metabolites in rabbit intestine","volume":"8","author":"Riad","year":"1991","journal-title":"Pharm. Res. (N. Y.)"},{"key":"10.1016\/j.jddst.2022.103587_bib48","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/bdd.487","article-title":"Intestinal absorption andpresystemic disposition of sildenafil citrate in the rabbit: evidence for site dependent absorptive clearance","volume":"27","author":"Osman","year":"2006","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.jddst.2022.103587_bib49","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/jphp.12516","article-title":"Colloidal carriers for extended absorption window of furosemide","volume":"68","author":"Sultan","year":"2016","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jddst.2022.103587_bib50","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s40005-018-0403-7","article-title":"Formulation and evaluation of spray dried liposomes of lopinavir for topical application","volume":"49","author":"Maniyar","year":"2019","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.jddst.2022.103587_bib51","doi-asserted-by":"crossref","DOI":"10.4172\/2329-9053.1000128","article-title":"Structural and physical properties of biofield treated thymol and menthol","volume":"3","author":"Trivedi","year":"2015","journal-title":"J. Mol. Pharm. Org. Process. Res."},{"key":"10.1016\/j.jddst.2022.103587_bib52","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jfoodeng.2017.12.020","article-title":"Menthol\/cyclodextrin inclusion complex nanofibers: enhanced water solubility and high-temperature stability of menthol","volume":"224","author":"Yildiz","year":"2018","journal-title":"J. Food Eng."},{"key":"10.1016\/j.jddst.2022.103587_bib53","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.molliq.2019.04.001","article-title":"Spectral and thermophysical properties of some novel deep eutectic solvent based on l-menthol and their mixtures with ethanol","volume":"285","author":"Abri","year":"2019","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.jddst.2022.103587_bib54","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejps.2010.10.002","article-title":"Lopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targeting","volume":"42","author":"Alex","year":"2011","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.jddst.2022.103587_bib55","doi-asserted-by":"crossref","first-page":"193","DOI":"10.29090\/psa.2019.03.018.0020","article-title":"Design and characterisation of lopinavir nanocrystals for solubility and dissolution enhancement","volume":"46","author":"Shinde","year":"2019","journal-title":"Pharm. Sci. Asia."},{"key":"10.1016\/j.jddst.2022.103587_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodhyd.2021.106631","article-title":"Design and characterization of starch\/solid lipids hybrid microcapsules and their thermal stability with menthol","volume":"116","author":"Sun","year":"2021","journal-title":"Food Hydrocolloids"},{"key":"10.1016\/j.jddst.2022.103587_bib57","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ejps.2004.08.008","article-title":"Preparation of ibuprofen-loaded liquid suppository using eutectic mixture system with menthol","volume":"23","author":"Yong","year":"2004","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.jddst.2022.103587_bib58","article-title":"Therapeutic deep eutectic system of capric acid and menthol: characterization and pharmaceutical application","volume":"53","author":"Al-Akayleh","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.jddst.2022.103587_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2020.111149","article-title":"Central composite design-based optimization of lopinavir vitamin E-TPGS micelle: in vitro characterization and in vivo pharmacokinetic study","volume":"194","author":"Mahajan","year":"2020","journal-title":"Colloids Surf., B"},{"key":"10.1016\/j.jddst.2022.103587_bib60","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1080\/03639045.2019.1571504","article-title":"Co-crystallization for enhanced dissolution rate of bicalutamide: preparation and evaluation of rapidly disintegrating tablets","volume":"45","author":"Essa","year":"2019","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jddst.2022.103587_bib61","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0032-3861(66)80015-0","article-title":"Cocrystallization in copolymers of \u03b1-olefins II\u2014butene-1 copolymers and polybutene type II\/I crystal phase transition","volume":"7","author":"Jones","year":"1966","journal-title":"polymer"},{"key":"10.1016\/j.jddst.2022.103587_bib62","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1136\/gut.14.9.683","article-title":"Small intestine permeability in animal and man","volume":"14","author":"Loehry","year":"1973","journal-title":"Gut"},{"key":"10.1016\/j.jddst.2022.103587_bib63","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/jps.2600660117","article-title":"Use of rabbits for GI drug absorption studies","volume":"66","author":"Maeda","year":"1977","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.jddst.2022.103587_bib64","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1124\/jpet.102.041236","article-title":"Region-dependent modulation of intestinal permeability by drug efflux transporters: in vitro studies in mdr1a (\u2212\/\u2212) mouse intestine","volume":"303","author":"Stephens","year":"2002","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.jddst.2022.103587_bib65","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1023\/A:1026183200740","article-title":"P-glycoprotein increases from proximal to distal regions of human small intestine","volume":"20","author":"Mouly","year":"2003","journal-title":"Pharm. Res. (N. Y.)"},{"key":"10.1016\/j.jddst.2022.103587_bib66","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/jphp.13036","article-title":"Regional difference in intestinal drug absorption as a measure for the potential effect of P-glycoprotein efflux transporters","volume":"71","author":"Ashmawy","year":"2019","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jddst.2022.103587_bib67","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1021\/js9701465","article-title":"Testosterone skin permeation enhancement by menthol through formation of eutectic with drug and interaction with skin lipids","volume":"86","author":"Kaplun-Frischoff","year":"1997","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.jddst.2022.103587_bib68","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0378-5173(99)00301-4","article-title":"Transbuccal permeation of a nucleoside analog, dideoxycytidine: effects of menthol as a permeation enhancer","volume":"192","author":"Shojaei","year":"1999","journal-title":"Int. J. Pharm."}],"container-title":["Journal of Drug Delivery Science and Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1773224722004981?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1773224722004981?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T04:45:23Z","timestamp":1761713123000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1773224722004981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":68,"alternative-id":["S1773224722004981"],"URL":"https:\/\/doi.org\/10.1016\/j.jddst.2022.103587","relation":{},"ISSN":["1773-2247"],"issn-type":[{"value":"1773-2247","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lopinavir-menthol co-crystals for enhanced dissolution rate and intestinal absorption","name":"articletitle","label":"Article Title"},{"value":"Journal of Drug Delivery Science and Technology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jddst.2022.103587","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103587"}}